Newsroom

GSK plans expansion of Solara clinical trial strategy platform to optimize design selection across therapeutic areas

Quantitative bias analysis (QBA) is a potential and likely breakthrough in real-world evidence. This was the conclusion..

WALTHAM, MASSACHUSETTS — Cytel Inc., a leading provider of innovative clinical trial designs, advanced analytics, and..

  Solara clinical trial strategy platform recognized for transformative innovation WALTHAM, MASS - Cytel Inc., a..

WALTHAM, MASSACHUSETTS -- A new partnership between Cytel Inc., a global health analytics firm, and South Korea's Trial..

WALTHAM, MASS - Cytel Inc., creators of Solara®, a platform for high-compute, simulation-guided clinical trial..

Waltham, MA, October 13, 2022 – Cytel Inc., provider of quantitative insights and health data analytics to leaders in..

WALTHAM, MASS - Cytel Inc., a pioneer of adaptive clinical trial design and provider of advanced biometrics services,..

WALTHAM, MASS - Cytel Inc. and F. Hoffman-La Roche Ltd., have partnered together to pioneer the application of a unique..

WALTHAM, MASS - The TOGETHER Trial for COVID-19 therapies, designed by clinical trial specialists at Cytel Inc., has..

Joint efforts recognize the global pandemic impact on the staging of cancer cases in the United States at the..

WALTHAM, MASS - Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving..

March 7, 2022 — Research scientists at The Trevor Project, the world’s largest suicide prevention and mental health..

Cytel believes dialogue is pivotal towards progress. Here are a list of our 2021 webinars. The Long-term Industry..

Pictured: Dr. Radek Wasiak, Chief Data Officer & Head of Real World and Advanced Analytics at Cytel and Dr. Femida..

A clinical trial tracker aims to encourage international collaboration on COVID-19

Using Cytel’s expertise, the TOGETHER Trial simultaneously tests multiple repurposed therapies

Updated March 1, 2022: Cytel will be attending the Citeline awards ceremony in April. WALTHAM, MASS - Cytel’s new trial..

Cytel and its collaborators have analyzed the challenges of conducting high-quality clinical research in LMICs – a..

WALTHAM, MASS - Cytel Inc. is pleased to announce that renowned Bayesian clinical trial design specialist Dr Kyle..

WALTHAM, MASS -  After months of successfully deploying its new strategic decision-support software Solara, Cytel Inc.,..

Waltham, MA, March 8, 2021 – Cytel Inc. has launched East® Bayes, an enhanced web-based extension of the East® platform..

Cytel is one of the leading global providers of clinical trial design technology, biometric services and advanced..

New Acquisition Further Expands Cytel’s Global Consultancy in Health Economics Outcomes Research and Value..

Waltham, MA, October 6, 2020 – Cytel Inc. has launched SolaraTM, a collaborative decision-support platform that..

Two South Africa sites added to TOGETHER platform trials for the outpatient treatment of high-risk adults infected with..

Cytel Inc. has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in..

Cytel Inc., an advanced 

Global COVID-19 Clinical Trial Tracker Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to..

Collaboration to accelerate new clinical trial technologies and techniques for disease-focused RWE production Clinical..

Waltham MA, March 04, 2020 — A new paper authored by statistical experts at Cytel has been published in the..

Copenhagen, Denmark —ISPOR Europe 2019 —November 05 2019—Cytel Inc. (“Cytel” or the “Company”), the leading provider of..

Cytel Inc., the leading global provider of innovative analytical software and consulting services to the life sciences..

Cytel Inc., the leading global provider of analytical solutions to the life sciences industry, today announced that it..

Cytel Inc., the leading global provider of innovative analytical software and services to the life sciences industry,..

Cytel announced the appointment of Joshua Schultz as Chief Executive Officer (CEO) effective January 7th, 2019. He..

Cytel announced the launch of OK GO, the first commercially available software to underpin quantitative go/no-go..

Cytel has won Best Contract Research Organization( CRO) – Specialist Providers at the 2018 Scrip Awards. The accolade..

Cytel Inc., a global provider of advanced analytical solutions to the pharmaceutical, biotechnology, and medical device..

Cytel Inc., a global provider of innovative analytical software and services to the biopharmaceutical industry, today..

Cytel announces the launch of its East Lite app on iOS. Developed by the team responsible for East, East Lite features..

Cytel is confirmed as a finalist in Most Innovative Trial Design and Clinical Partnership of the Year categories at the..

Congratulations to Lipopharma and the CLINGLIO project consortium on their recent 6,15M€ grant award by the European..

Cytel is confirmed as a finalist in Most Innovative Trial Design and Best Sponsor-focused Technological Development..